ADVERTISEMENT

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

Psilocybin may be safe and effective as treatment for MDD Psilocybin may be safe and effective as treatment for MDD

Psilocybin may be safe and effective as treatment for MDD

Results from a new study published in JAMA find that among patients with major depressive disorder (MDD), a single 25-mg dose of psilocybin led to...
0 5386
Could GLP-1s benefit T1D patients, too? Could GLP-1s benefit T1D patients, too?

Could GLP-1s benefit T1D patients, too?

The popular GLP-1 receptor agonists, originally approved for T2D, may also be beneficial for patients with T1D—at least, that’s what...
0 5235
CDC: Overdose deaths from counterfeit drugs on the rise CDC: Overdose deaths from counterfeit drugs on the rise

CDC: Overdose deaths from counterfeit drugs on the rise

A new report from CDC finds that in recent years, the number of people who overdosed and died from counterfeit prescription drugs has more than...
0 10237
Postnatal SSRI treatment could benefit both mother and child Postnatal SSRI treatment could benefit both mother and child

Postnatal SSRI treatment could benefit both mother and child

Findings from a recent study published in JAMA Network Open suggest that postnatal SSRI treatment may bring benefits in the long term to not only...
0 9320

Is PPI use connected to dementia risk?

The prolonged use of PPI drugs, which are designed to control acid reflux and other gastrointestinal disorders, may raise the risk of dementia, according to a new study in Neurology.

CDC: MMR vaccinations fall for children

According to new CDC data, the rate of vaccinations against measles, mumps, and rubella (MMR) for kindergarteners has fallen below the optimum target rate of 95% for the second year in a row, declining to 93%.

First567810121314Last
Advertisement
Advertisement
Advertisement
Advertisement

ADVERTISEMENT